Weefen 222 Mg

What Is Weefen 222 mg?

Weefen 222 mg is a Fenbendazole-based antiparasitic tablet produced by Weefsel Pharma. Fenbendazole belongs to the benzimidazole class of anthelmintic compounds with an established record of use in veterinary medicine for treating and controlling a variety of parasitic worm infections in animals.

The 222mg strength sits between the lower 150mg entry-level formulation and the higher 444mg and 500mg strengths in the Weefen product range — making it a practical intermediate dosing option within the Weefen Fenbendazole lineup as determined by a qualified professional.

Weefsel Pharma produces Weefen Fenbendazole across four strengths — 150mg, 222mg, 444mg, and 500mg — to accommodate different dosing and weight-based requirements across varied clinical and veterinary contexts.

Manufacturer Details

Weefen 222 mg Tablets are manufactured by Weefsel Pharma, a pharmaceutical manufacturer producing Fenbendazole formulations in certified pharmaceutical facilities. Manufacturing is conducted under stringent quality control standards with comprehensive batch testing to ensure consistent product purity, potency, and safety in every tablet.

How Does Weefen Fenbendazole 222 mg Work?

• After administration, Fenbendazole is absorbed and reaches susceptible parasitic organisms within the body
• It binds specifically to beta-tubulin proteins present in parasitic worm cells
• Beta-tubulin is a critical structural protein parasites depend on to form microtubules — internal cellular structures essential for nutrient transport, energy metabolism, and cell division
• By binding to beta-tubulin, Fenbendazole disrupts microtubule polymerization — preventing correct formation of these essential cellular structures
• Without functional microtubules, the parasite loses its capacity to absorb glucose for energy production
• This leads to progressive energy depletion, structural breakdown, and eventual natural elimination of the parasite from the body